NeuroPace

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, NeuroPace sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 4 completed upper quartile by trial count

NeuroPace: 8 sponsored US clinical trials, none currently recruiting.

NeuroPace sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 3 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Epilepsy, with 4 trials.

Upper-quartile sponsor footprint

NeuroPace sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 2

RNS System LGS Feasibility Study

NCT05339126
ACTIVE NOT RECRUITING Phase 3

RNS System NAUTILUS Study

NCT05147571
ACTIVE NOT RECRUITING

RNS® System Epilepsy Post-Approval Study

NCT02403843
TERMINATED NA

RNS System RESPONSE Study

NCT04839601
COMPLETED Phase 4

RNS® System LTT Study

NCT00572195
COMPLETED Phase 3

RNS® System Pivotal Study

NCT00264810
COMPLETED Phase 2

RNS® System Feasibility Study

NCT00079781
COMPLETED Phase 2

Study of an External Responsive Neurostimulator System on Epileptiform Activity

NCT00158067

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 2
Phase 4 1

Therapeutic Areas

Epilepsy 4
Seizures, Generalized 1
Lennox-Gastaut Syndrome, Intractable 1
Idiopathic Generalized Epilepsy 1
Generalized Tonic Clonic Seizure 1
Lennox Gastaut Syndrome 1
Seizures 1

How the NeuroPace archive is shaped

8 indexed studies, none listed as recruiting (0% open); 4 completed (50%).

Phase mix: 3 late (III/IV) vs 3 early (I/II) (balanced across stages).

Top condition: Epilepsy (4 trials), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

NeuroPace: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

NeuroPace sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share NeuroPaceAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
NeuroPace sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

NeuroPace sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this NeuroPace page

8 registered trials is a research-attention snapshot, not an endorsement of NeuroPace or any single study.

  • None of NeuroPace's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Epilepsy is the condition NeuroPace studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Epilepsy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

NeuroPace pipeline card: 8 registered trials from official public datasets.Report a data error.